Search Within

Steven M Horwitz

Formats
  1. Meeting Abstract (374)
  2. Journal Article (244)
  3. Review (13)
  4. Guidelines (10)
  5. Research Letter (9)
  6. Book Section (6)
  7. Editorial (4)
  8. Correspondence (3)
  9. Miscellaneous (1)
Groups
  1. Center for Hematologic Malignancies (664)
  2. Department of Medicine (664)
  3. Hematologic Malignancies, Division of (664)
  4. Lymphoma (664)
  5. Population Sciences Research Program (664)
  6. Survivorship Research (170)

More Groups

People
  1. Alison Moskowitz (231)
  2. Andrew Zelenetz (166)
  3. Paul Hamlin (137)
  4. Ariela Noy (136)
  5. David Straus (121)
  6. Maria Palomba (109)

More People

Years
  1. 2025 (12)
  2. 2024 (50)
  3. 2023 (41)
  4. 2022 (34)
  5. 2021 (53)
  6. 2020 (52)

More Years

Publications
  1. Blood (255)
  2. Journal of Clinical Oncology (64)
  3. Hematological Oncology (38)
  4. Annals of Oncology (18)
  5. Blood Advances (18)
  6. Leukemia and Lymphoma (18)

More Publications

Publishers
  1. American Society of Hematology (276)
  2. American Society of Clinical Oncology (65)
  3. Wiley Blackwell (55)
  4. Elsevier Inc. (33)
  5. Oxford University Press (25)
  6. Taylor & Francis Group (22)

More Publishers

Results (664)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Adult T-cell leukemia/lymphoma with follicular mucinosis: An unusual histopathological finding and a commentary
    Journal Article

    Camp, B.; Horwitz, S.; Pulitzer, M. P.
    Journal of Cutaneous Pathology (2012)

    Fulltext@MSK | Save
  • Pralatrexate is an effective treatment for relapsed or refractory transformed mycosis fungoides: A subgroup efficacy analysis from the PROPEL study
    Journal Article

    Foss, F.; Horwitz, S. M.; Coiffier, B.; Bartlett, N.; Popplewell, L.; Pro, B.; Pinter-Brown, L. C.; Shustov, A.; Furman, R. R.; Haioun, C.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2012)

    Fulltext@MSK | Save
  • Romidepsin for previously treated patients with peripheral or aggressive T-cell lymphomas
    Journal Article

    Horwitz, S. M.
    Clinical Advances in Hematology & Oncology (2012)

    Fulltext@MSK | Save
  • Identification of an active, well-tolerated dose of pralatrexate in patients with relapsed or refractory cutaneous T-cell lymphoma
    Journal Article

    Horwitz, S. M.; Kim, Y. H.; Foss, F.; Zain, J. M.; Myskowski, P. L.; Lechowicz, M. J.; Fisher, D. C.; Shustov, A. R.; Bartlett, N. L.; Delioukina, M. L.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Long-term survival in patients with peripheral T-cell non-Hodgkin lymphomas after allogeneic hematopoietic stem cell transplant
    Journal Article

    Goldberg, J. D.; Chou, J. F.; Horwitz, S.; Teruya-Feldstein, J.; Barker, J. N.; Boulad, F.; Castro-Malaspina, H.; Giralt, S.; Jakubowski, A. A.; Koehne, G.; more...
    Leukemia and Lymphoma (2012)

    Fulltext@MSK | Save
  • Exploratory study of brentuximab vedotin (SGN-35), a novel monoclonal antibody-drug-conjugate against CD30, in mycosis fungoides (MF) and Sézary syndrome (SS) demonstrates clinical responses regardless of CD30 expression levels
    Meeting Abstract

    Bashey, S.; Krathen, M.; Sutherland, K.; Sundram, U.; Lingala, B.; Horwitz, S.; Hoppe, R.; Pulitzer, M.; Advani, R.; Kim, Y.
    Journal of Investigative Dermatology (2012)

    Fulltext@MSK | Save
  • Management of cutaneous T cell lymphoma: New and emerging targets and treatment options
    Journal Article

    Li, J. Y.; Horwitz, S.; Moskowitz, A.; Myskowski, P. L.; Pulitzer, M.; Querfeld, C.
    Cancer Management and Research (2012)

    Fulltext@MSK | Save
  • RAS mutation analysis of transformed mycosis fungoides identifies a KRAS G13D mutation
    Meeting Abstract

    Connolly, B. M.; Hedvat, C.; Myskowski, P. L.; Horwitz, S. M.; Pulitzer, M. P.
    Modern Pathology (2012)

    Fulltext@MSK | Save
  • RAS mutation analysis of transformed mycosis fungoides identifies a KRAS G13D mutation
    Meeting Abstract

    Connolly, B. M.; Hedvat, C.; Myskowski, P. L.; Horwitz, S. M.; Pulitzer, M. P.
    Laboratory Investigation (2012)

    Fulltext@MSK | Save
  • Normalization of pre-ASCT, FDG-PET imaging with second-line, non-cross-resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphoma
    Journal Article

    Moskowitz, C. H.; Matasar, M. J.; Zelenetz, A. D.; Nimer, S. D.; Gerecitano, J.; Hamlin, P.; Horwitz, S.; Moskowitz, A. J.; Noy, A.; Palomba, L.; more...
    Blood (2012)

    Fulltext@MSK | Save